Data secrecy is crippling attempts to slow COVID-19’s spread in U.S., epidemiologists warn
California scientists have been denied access to detailed data on the pandemic by state and local officials
Science Fund for Investigative Reporting
Read our COVID-19 research and news.
-
-
Who’s to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal
Author partnership on coronavirus papers is “completely bizarre” and should have been a red flag, former journal editor says -
Emails offer look into whistleblower charges of cronyism behind potential COVID-19 drug
Demoted pandemic official expressed concern about safety of unproven coronavirus drug -
Female scientists allege discrimination, neglect of research on women at NIH’s child health institute
Eight women filed bias complaints naming scientific director Constantine Stratakis -
How women at NIH’s research hospital lost chances at childbearing
Egg freezing was suspended for more than 3 years, angering infertility experts -
NIH extends reporting mandate to more clinical trials, but obscures their policing
Agency’s approach to enforcement called “regulatory theater” -
FDA and NIH let clinical trial sponsors keep results secret and break the law
Science investigation of ClinicalTrials.gov reveals that federal promises to enforce trial transparency have fizzled -
Clinical scofflaws?
A Science investigation identifies some of the worst recent offenders of the clinical trials reporting law -
Investigation reveals widespread double dipping in NIH program to pay off school debt
Program aims to keep young scientists from moving to pharma, but many take industry money anyway -
Science chief at NIH drug abuse institute resigned after sexual misconduct probe
NIH sources unhappy with leaders’ silence on reasons for Antonello Bonci’s departure -
Exclusive: FDA enforcement actions plummet under Trump
FDA actions that safeguard clinical trials, food and drug safety in steep decline, Science investigation reveals -
Exclusive: Major U.S. cancer center ousts ‘Asian’ researchers after NIH flags their foreign ties
Chinese American community fears ethnic targeting at MD Anderson by the Federal Bureau of Investigation and National Institutes of Health -
The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine?
A third of Americans are considered prediabetic—but many may be better off without treatment -
Private research funders court controversy with billions in secretive investments
Critics say offshore investing by high-minded foundations shores up a nefarious system -
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy
Compiling the evidence from dozens of studies doesn't always bring clarity -
Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns
Science investigation of journal disclosures and pharmaceutical funding records shows potential influence on physician gatekeepers
